(Q24236388)

English

Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors (English)

0 references

0 references

0 references

Roberto D'Amico

3

0 references

1

object named as

Alfonso Iorio

0 references

author name string

Davide Matino

2

0 references

Michael Makris

4

0 references

publication date

4 August 2010

0 references

Cochrane Database of Systematic Reviews

0 references

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Single 270 microg kg(-1)-dose rFVIIa vs. standard 90 microg kg(-1)-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Marginal modeling of binary cross-over data

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Inhibitors: resolving diagnostic and therapeutic dilemmas

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Inhibitor development in haemophilia B: an orphan disease in need of attention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Meta-analyses involving cross-over trials: methodological issues

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Inhibitor development in previously untreated patients with hemophilia A: a prospective long-term follow-up comparing plasma-derived and recombinant products

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Control of bleeding in patients with haemophilia A with inhibitors: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

The hemophilias--from royal genes to gene therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Treatment of haemophilia in the United Kingdom 1981-1996.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

Factor VIII inhibitors in haemophiliacs: a single-centre experience over 34 years, 1964-97.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

21 January 2018

FEIBA in haemophiliacs with factor VIII inhibitor

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004449.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD004449.PUB3

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24236388&oldid=2010822700"